Selecta Biosciences raises $38 mln
Selecta Biosciences Inc. said Tuesday it raised $38 million in a Series E financing round. OrbiMed is the largest investor in the round which includes new investors, Sanofi-Genzyme BioVentures, Ridgeback Capital Management, Osage University Partners, AJU IB Investment and Sphera Global Health Care Fund. All of Selecta’s existing investors also participated. Watertown, Massachusetts-based Selecta is clinical stage biotechnology company.
8 September 2015•4 mins read
